Innovatus Imaging Launches TEE Probe Maintenance Program

Trans-Esophageal Echocardiology, or TEE Probes, used to create images of the heart via the esophagus, are among the most costly ultrasound devices imaging departments nationwide purchase in order to properly diagnose cardiac conditions. Each of these highly...

Clarius to Unveil Miniaturized Wireless Smartphone Ultrasound Scanners

Clarius Mobile Health is poised to deliver on its promise to make high-definition ultrasound more affordable and easier to use for every clinician. During its virtual Innovation Spotlight event on Monday, January 17, 2022, the company’s ultrasound pioneers will take...

AHRA Approves ICE Education

ICE 2022 is approved for 32 ARRT Category A CE credits by AHRA.

MUSC team demonstrates MRI scan in ambulance

Doctors at MUSC Health’s Comprehensive Stroke Center constantly work with their community hospital colleagues on initiatives to cut down the steps that need to happen between the time a stroke patient is wheeled through the ambulance bay until treatment can begin.

QMENTA Inc. Announces FDA 510(k) Clearance

QMENTA announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its QMENTA Platform for Care. This 510(k) clearance enables suitably qualified physicians to use the platform to manage imaging and other data across a network via web and customized user interfaces, and process it by accessing and using integrated AI marketed applications for imaging analysis and reporting.

The 510(k) clearance (K202718) for the QMENTA Platform for Care (formally named The QMENTA Care Family Platform) is one of the more recently highlighted medical devices reviewed and authorized by the FDA in their tracking of Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices.

Using the QMENTA Platform for Care, clinicians can simply and compliantly manage imaging data and apply marketed AI-enabled tools to visualize and gain quantified insights into features and changes in the brain. These marketed AI-enabled tools are hosted in the QMENTA Medical Imaging AI Analyses Catalog, a comprehensive set of over 50 marketed and research-only AI algorithms from verified, trusted scientific leaders focused on neurology. These world-leading AI algorithms and biomarker tools assist with quantification and analysis of disease onset and progression assessment, diagnosis and prognosis.

QMENTA CEO Vesna Prchkovska said, “FDA clearance for the QMENTA Care Platform is an exciting milestone for the industry, opening and democratizing access to the latest AI-powered imaging management and analysis tools.”



Submit a Comment

Your email address will not be published. Required fields are marked *